Feasibility and Efficacy of Cohort Enrichment for Progressive Lung Fibrosis in Systemic Sclerosis - a EUSTAR Database Analysis

被引：0
|
作者：
Hoffmann-Vold, A. [1 ]
Gahlemann, M. [2 ]
Graf, N. [3 ]
Airo, P. [4 ]
Ananyeva, L. P. [5 ]
Czirjak, L. [6 ]
Guiducci, S. [7 ]
Hachulla, E. [8 ]
Li, M. [9 ]
Mihai, C. [10 ]
Riemekasten, G. [11 ]
Sfikakis, P. [12 ]
Valentini, G. [13 ]
Kowal-Bielecka, O. [14 ]
Allanore, Y. [15 ]
Distler, O. [10 ]
机构：
[1] Oslo Univ Hosp, Dept Rheumatol, Oslo, Norway
[2] Boehringer Ingelheim Schweiz GmbH, Basel, Switzerland
[3] Graf Biostat, Winterthur, Switzerland
[4] Spedali Civili Brescia, UO Reumatol & Immunol Clin, Brescia, Italy
[5] VA Nasonova Inst Rheumatol, Moscow, Russia
[6] Univ Pecs, Dept Rheumatol & Immunol, Pecs, Hungary
[7] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy
[8] Univ Lille, Dept Internal Med & Clin Immunol, Hop Claude Huriez, Lille, France
[9] Peking Union Med Coll Hosp West Campus, Dept Rheumatol, Beijing, Peoples R China
[10] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[11] Univ Med Ctr Schleswig Holstein, Dept Rheumatol & Clin Immunol, Kiellubeck, Germany
[12] Univ Athens, Joint Rheumatol Programme, Med Sch, Athens, Greece
[13] II Policlin UO Reumatol, Dipartimento Med Precis, Naples, Italy
[14] Med Univ Bialystok, Dept Rheumatol & Internal Med, Bialystok, Poland
[15] Descartes Univ, Cochin Hosp, APHP, Dept Rheumatol A, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5614
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PREDICTION OF IMPROVEMENT IN SKIN FIBROSIS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS - A EUSTAR ANALYSIS
    Dobrota, R.
    Maurer, B.
    Graf, N.
    Mihai, C.
    Kowal-Bielecka, O.
    Allanore, Y.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 819 - 819
  • [32] Progressive Skin Fibrosis is Associated with Lung Function Decline and Poorer Survival in Patients with Diffuse Cutaneous Systemic Sclerosis: a European Scleroderma Trials and Research (EUSTAR) Analysis
    Wu Wanlong
    Jordan, Suzana
    Graf, Nicole
    Pena, Janethe
    Curram, John
    Allanore, Yannick
    Matucci-Cerinic, Marco
    Pope, Janet
    Denton, Christopher
    Khanna, Dinesh
    Distler, Oliver
    SWISS MEDICAL WEEKLY, 2018, 148 : 10S - 10S
  • [33] PROGRESSIVE SKIN FIBROSIS IS ASSOCIATED WITH A DECLINE IN LUNG FUNCTION AND POORER SURVIVAL IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) ANALYSIS
    Wu, W.
    Jordan, S.
    Graf, N.
    Pena, J.
    Curram, J.
    Allanore, Y.
    Matucci-Cerinic, M.
    Pope, J. E.
    Denton, C.
    Khanna, D.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1112 - 1113
  • [34] SMOKING INFLUENCE ON AUTOANTIBODY PROFILE AND DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS: AN EUSTAR DATABASE ANALYSIS
    Ciaffi, J.
    Liem, S.
    Wiland, P.
    Atsumi, T.
    Szucs, G.
    Pellerito, R.
    Balbir-Gurman, A.
    Czirjak, L.
    Zanatta, E.
    Koetter, I.
    Shah, A.
    Henes, J.
    Matucci-Cerinic, M.
    Airo, P.
    Ursini, F.
    Huizinga, T.
    De Vries-Bouwstra, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 975 - 975
  • [35] Can Immunosuppression or Vasodilation Prevent the Onset of Interstitial Lung Disease in Systemic Sclerosis? An Association Analysis from the EUSTAR Database
    Petelytska, Liubov
    Tofani, Lorenzo
    Siegert, Elise
    Zanatta, Elisabetta
    Moroncini, Gianluca
    Bergmann, Christina
    Smith, Vanessa
    Riemekasten, Gabriela
    Solanki, Kamal
    Cacciapaglia, Fabio
    Maurer, Britta
    da Silva, Jose
    Geroldinger-Simic, Marija
    Rodrigues, Ana
    Vonk, Madelon
    de Vries-Bouwstra, Jeska
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Bruni, Cosimo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1435 - 1438
  • [36] IS AN IMPROVEMENT IN SKIN FIBROSIS ASSOCIATED WITH BETTER OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS? A EUSTAR ANALYSIS
    Wyss, A.
    Jordan, S.
    Graf, N.
    Siegert, E.
    Czirjak, L.
    Doria, A.
    Giollo, A.
    Rosato, E.
    Hoffmann-Vold, A. M.
    Gabrielli, A.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 713 - 713
  • [37] Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
    Hoffmann-Vold, Anna -Maria
    Brunborg, Cathrine
    Airo, Paolo
    Ananyeva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Valentini, Gabriele
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    CHEST, 2023, 163 (03) : 586 - 598
  • [38] Characteristics and disease course of systemic sclerosis patients with interstitial lung disease and gastroesophageal reflux disease - an analysis of the EUSTAR cohort
    Roth, E.
    Bruni, C.
    Liubov, P.
    Carreira, P.
    De Vries-Bouwstra, J.
    Balbir-Gurman, A.
    Liakouli, V
    Moroncini, G.
    Bergmann, C.
    Mouthon, L.
    Denton, C.
    De Santis, M.
    Cauli, A.
    Hasler, P.
    Bernardino, V
    Truchetet, M.
    Vonk, M.
    Del Galdo, F.
    Hoffmann-Vold, A.
    Distler, O.
    Elhai, M.
    SWISS MEDICAL WEEKLY, 2024, 154 : 11S - 11S
  • [39] Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region (vol 6, pg 2178, 2023)
    Lescoat, Alain
    RHEUMATOLOGY, 2023, 62 (09) : 3219 - 3220
  • [40] FACTORS TO CONSIDER FOR MEASURING THE EFFECT OF LUNG FUNCTION ON PATIENT REPORTED OUTCOMES IN SYSTEMIC SCLEROSIS PATIENTS: ANALYSIS OF THE EUSTAR DATABASE.
    Lazzaroni, M. G.
    Wilson, M.
    Hensor, E.
    Distler, J. H. W.
    Cuomo, G.
    Siegert, E.
    Mueller-Ladner, U.
    Allanore, Y.
    Salvador, M. J.
    Anic, B.
    Walker, U.
    Czirjak, L.
    Ribi, C.
    Tanaseanu, C. M.
    Gabrielli, A.
    Hoffmann-Vold, A. M.
    Distler, O.
    Del Galdo, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 743 - 744
12345